Trovo Health: $15 Million Raised To Enable Healthcare Providers To Extend Services

By Amit Chowdhry • May 3, 2024

Trovo Health announced that it is launching with a $15 million fundraise led by Oak HC/FT. Trovo uses an AI-powered platform backed by a multidisciplinary care team to help providers extend their capabilities. In connection with the funding, Andrew Adams, co-founder and managing partner at Oak HC/FT, will join the board of directors at Trovo Health.

Trovo Health, based in New York City, was co-founded by Niren Gandra, M.D., and Aditya Pandyaram. Its platform helps physician groups add new capabilities, including complex tasks requiring specialty-specific expertise. Providers can use the platform to improve outcomes, deliver a better patient experience, and improve their own operations.

The company built a team of clinicians and technologists to deliver on its vision. It plans to use the funding to further build out its technology platform, clinical operations and leadership team.

KEY QUOTES:

“Adding new practice capabilities, both internal and patient-facing, has always been a challenge for practices. By combining specialty-specific AI with expert clinical team members, we can help providers tackle historically difficult problems with a click of a button.”

  • Niren Gandra, M.D., CEO and co-founder of Trovo Health

 “Trovo’s platform introduces an innovative solution for the most challenging problems in care delivery and operations. We are proud to partner with Niren, Aditya and the Trovo team on their journey to making healthcare services more straightforward for patients and physicians alike.”

  • Andrew Adams, co-founder and managing partner at Oak HC/FT

“Trovo’s approach is exciting because they are combining cutting edge technology with the expertise of a medical group. Trovo has the ability to support customers across multiple use cases with a singular platform and completely handle complicated workflows, rather than offer a piecemeal solution.”

  • Vig Chandramouli, partner at Oak HC/FT